1887

Abstract

Traditionally, bacteria in The Netherlands have low levels of resistance to antibiotics. This report describes what is believed to be the first carbapenem-resistant producing an OXA-48 type β-lactamase in The Netherlands. The isolate co-produced a CTX-M-15 type β-lactamase and was recovered from a patient who was transferred from a hospital in India to an intensive care unit in The Netherlands. His recovery in The Netherlands was complicated by pneumonia due to the carbapenem-resistant to which he eventually succumbed. Pre-emptive screening for carbapenem-resistant in selected patients could be imperative to maintain the low prevalence of these highly resistant bacteria in Dutch hospitals.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.028308-0
2011-05-01
2020-07-09
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/5/677.html?itemId=/content/journal/jmm/10.1099/jmm.0.028308-0&mimeType=html&fmt=ahah

References

  1. Bell, J. M., Mathai, D., Jones, R. N. & Turnidge, J. D. (2009 Emergence of OXA-48 carbapenemases among Klebsiella spp. from India. In: Abstracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), abstract C2–650. Washington, DC: American Society for Microbiology
  2. Bradford P. A., Urban C., Mariano N., Projan S. J., Rahal J. J., Bush K. 1997; Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41:563–569[PubMed]
    [Google Scholar]
  3. Castanheira M., Deshpande L. M., Mathai D., Bell J. M., Jones R. N., Mendes R. E. 2011; Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program (2006–2007). Antimicrob Agents Chemother (in press) [PubMed]
    [Google Scholar]
  4. Cuzon G., Naas T., Bogaerts P., Glupczynski Y., Huang T. D., Nordmann P. 2008a; Plasmid-encoded carbapenem-hydrolyzing β-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium. Antimicrob Agents Chemother 52:3463–3464 [CrossRef][PubMed]
    [Google Scholar]
  5. Cuzon G., Naas T., Demachy M. C., Nordmann P. 2008b; Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 52:796–797 [CrossRef][PubMed]
    [Google Scholar]
  6. Livermore D. M. 2009; Has the era of untreatable infections arrived?. J Antimicrob Chemother 64:Suppl. 1i29–i36 [CrossRef][PubMed]
    [Google Scholar]
  7. Poirel L., Héritier C., Tolün V., Nordmann P. 2004; Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15–22 [CrossRef][PubMed]
    [Google Scholar]
  8. Poirel L., Pitout J. D., Nordmann P. 2007; Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2:501–512 [CrossRef][PubMed]
    [Google Scholar]
  9. Poirel L., Ros A., Carricajo A., Berthelot P., Pozzetto B., Bernabeu S., Nordmann P. 2011; Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother 55:447–448 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.028308-0
Loading
/content/journal/jmm/10.1099/jmm.0.028308-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error